Sodium nitroprusside and Zinacef drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sodium nitroprusside and Zinacef. Common interactions include anxiety among females and anxiety among males.

The phase IV clinical study analyzes what interactions people who take Sodium nitroprusside and Zinacef have. It is created by eHealthMe based on reports of 9 people who take Sodium nitroprusside and Zinacef from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 25, 2022

9 people who take Sodium nitroprusside and Zinacef together, and have interactions are studied.


What is Sodium nitroprusside?

Sodium nitroprusside has active ingredients of sodium nitroprusside. eHealthMe is studying from 415 Sodium nitroprusside users for its effectiveness, alternative drugs and more.

What is Zinacef?

Zinacef has active ingredients of cefuroxime sodium. eHealthMe is studying from 1,771 Zinacef users for its effectiveness, alternative drugs and more.

Number of Sodium nitroprusside and Zinacef reports submitted per year:

Sodium nitroprusside and Zinacef drug interactions.

Common Sodium Nitroprusside and Zinacef drug interactions by gender *:

female:

  1. Anxiety
  2. Fear
  3. Pain
  4. Renal failure
  5. Anhedonia
  6. Depression
  7. Injury
  8. Myocardial infarction
  9. Sepsis
  10. Urinary tract infection

male:

  1. Anxiety
  2. Injury
  3. Cerebrovascular accident
  4. Death
  5. Depression
  6. Cardio-respiratory arrest
  7. Alanine aminotransferase increased
  8. Cardiac disorder
  9. Hypertension
  10. Myocardial infarction

Common Sodium Nitroprusside and Zinacef drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Emotional disorder
  3. Fear
  4. Pain
  5. Renal failure
  6. Renal impairment
  7. Renal injury
  8. Stress

30-39:

n/a

40-49:

n/a

50-59:

  1. Alanine aminotransferase increased
  2. Hypertension

60+:

  1. Anxiety
  2. Injury
  3. Myocardial infarction
  4. Renal impairment
  5. Cerebrovascular accident
  6. Death
  7. Sepsis
  8. Urinary tract infection
  9. Cardio-respiratory arrest
  10. Cardiac disorder

* Approximation only. Some reports may have incomplete information.

Do you take Sodium nitroprusside and Zinacef?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Sodium nitroprusside and Zinacef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Sodium nitroprusside interactions:

Browse all interactions between Sodium nitroprusside and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Zinacef interactions:

Browse all interactions between Zinacef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sodium nitroprusside and cefuroxime sodium (the active ingredients of Sodium nitroprusside and Zinacef, respectively), and Sodium nitroprusside and Zinacef (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Sodium nitroprusside and Zinacef.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: